Asilomar Bio closed $12.3 million in Series B financing, led by Syngenta Ventures. Mission Bay Capital, Cultivian Sandbox Venture Partners, Fall Line Capital, and Cavallo Ventures also participated in the funding. Asilomar Bio uses genomics, synthetic chemistry, agronomy, and data science tools to discover new